Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
about
Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trialsWhat does an adult rheumatologist need to know about juvenile idiopathic arthritis?Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case seriesTemporomandibular condylar alterations in juvenile idiopathic arthritis most common in longitudinally severe disease despite medical treatmentChildhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritisLong-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years.Canakinumab: a review of its use in the management of systemic juvenile idiopathic arthritis.Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.Treatment of adult-onset still's disease: up to date.Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.Outcome and Trends in Treatment of Systemic Juvenile Idiopathic Arthritis in the German National Pediatric Rheumatologic Database, 2000-2013.[Evidence of treatment of chronic inflammation in childhood and adolescence with biologics].Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization.Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan.
P2860
Q26775512-07561623-1592-4FA7-AAC8-F1E5320582B9Q26995394-EB0B6B88-357C-4C0F-8980-6792D082CDFBQ33712570-4877CE0E-4385-4AA9-AF66-4F7474480444Q34227357-633FB054-EFA4-493D-BBE6-6807E3186572Q35743755-704C6A0A-E61B-41AD-A8A3-8CF7E120E243Q37320554-9F8C0CDF-EC35-4EDB-B816-419CB54AA457Q38395697-88290F79-61DD-4665-912C-2260B9FDE673Q38406386-81262065-B1E5-441F-97D1-3F46B7BA7AD5Q38679486-27445D1C-C531-43A9-A4A3-873BA1BB6D06Q38711172-1613F2A5-4600-4BB9-B3CC-80E92901250DQ39663220-8D70FD6C-60EC-4E9A-A2C0-946055B57134Q40179129-D67B95AA-8C26-4AF1-A70F-C968D0A5028EQ51486721-9B3549E6-04F3-4A5F-A7B2-20F5B566264BQ52732724-26602DC5-459F-4126-A39A-D779A9E1E867
P2860
Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Efficacy of biological agents ...... ew using indirect comparisons.
@en
type
label
Efficacy of biological agents ...... ew using indirect comparisons.
@en
prefLabel
Efficacy of biological agents ...... ew using indirect comparisons.
@en
P2093
P2860
P31
P1476
Efficacy of biological agents ...... ew using indirect comparisons.
@en
P2093
Janneke Anink
Lisette W A van Suijlekom-Smit
Marieke H Otten
Sandra Spronk
P2860
P304
P356
10.1136/ANNRHEUMDIS-2012-201991
P407
P577
2012-11-21T00:00:00Z